We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Heritage Financial
HFWA
$1.15B
| $2.1M | 0.01% |
130,038
+4,495
| +4% | +$78.2K |
|
927
Independent Bank Corp
IBCP
$810M
| $2.1M | 0.01% |
123,683
-252
| -0.2% | -$4.32K |
|
|
X
928
DELISTED
US Steel
X
| $2.09M | 0.01% |
83,732
-15,806
| -16% | -$368K |
|
929
State Street Blackstone Senior Loan ETF
SRLN
$5.59B
| $2.09M | 0.01% |
+50,000
| New | +$2.07M |
|
930
OraSure Technologies
OSUR
$240M
| $2.09M | 0.01% |
416,795
-187
| -0% | -$1.12K |
|
931
Unum
UNM
$15B
| $2.07M | 0.01% |
43,494
+3,192
| +8% | +$139K |
|
932
B&G Foods
BGS
$255M
| $2.07M | 0.01% |
148,959
+70,195
| +89% | +$1.01M |
|
933
Adeia
ADEA
$2.75B
| $2.06M | 0.01% |
+186,756
| New | +$1.7M |
|
934
Ollie's Bargain Outlet
OLLI
$4.35B
| $2.05M | 0.01% |
35,371
-10,391
| -23% | -$640K |
|
935
CEVA Inc
CEVA
$783M
| $2.04M | 0.01% |
+80,013
| New | +$2.01M |
|
936
Lear
LEA
$6.08B
| $2.04M | 0.01% |
14,232
+652
| +5% | +$86.1K |
|
937
Brink's
BCO
$4.47B
| $2.02M | 0.01% |
29,850
+1,012
| +4% | +$67.7K |
|
938
Mission Produce
AVO
$1.09B
| $2.02M | 0.01% |
166,545
| – | – |
|
939
Graco
GGG
$12.4B
| $2.01M | 0.01% |
23,285
-1,564
| -6% | -$122K |
|
940
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $2.01M | 0.01% |
40,700
-22,300
| -35% | -$1.09M |
|
941
Roper Technologies
ROP
$37.2B
| $1.99M | ﹤0.01% |
4,146
-12
| -0.3% | -$5.43K |
|
942
United Therapeutics
UTHR
$21.4B
| $1.98M | ﹤0.01% |
8,979
-34
| -0.4% | -$7.53K |
|
943
MasterCraft Boat Holdings
MCFT
$466M
| $1.98M | ﹤0.01% |
64,564
-1,863
| -3% | -$53.8K |
|
944
Paysafe
PSFE
$327M
| $1.97M | ﹤0.01% |
195,371
+150,592
| +336% | +$1.91M |
|
945
Hurco Companies Inc
HURC
$147M
| $1.97M | ﹤0.01% |
90,903
-43
| -0% | -$973 |
|
|
RYZ
946
Ryerson Holding Corp
RYZ
$1.26B
| $1.96M | ﹤0.01% |
45,286
-8,246
| -15% | -$306K |
|
|
TWOU
947
DELISTED
2U Inc
TWOU
| $1.96M | ﹤0.01% |
16,230
+8,100
| +100% | +$1.08M |
|
948
Lumentum
LITE
$82.5B
| $1.95M | ﹤0.01% |
34,425
-240
| -0.7% | -$12K |
|
949
Arcosa
ACA
$7.13B
| $1.95M | ﹤0.01% |
25,735
-14,699
| -36% | -$988K |
|
950
Century Therapeutics
IPSC
$337M
| $1.94M | ﹤0.01% |
614,094
-550,517
| -47% | -$1.77M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.